These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 197220)

  • 61. Eradication of poliomyelitis.
    Wiysonge CS; Njamnshi AK; Nomo E; Shey MS
    Lancet; 2005 Oct; 366(9492):1163-4. PubMed ID: 16198762
    [No Abstract]   [Full Text] [Related]  

  • 62. Risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989-91.
    Andrus JK; Strebel PM; de Quadros CA; Olivé JM
    Bull World Health Organ; 1995; 73(1):33-40. PubMed ID: 7704923
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inactivated poliovirus vaccine and vaccine-associated paralytic poliomyelitis.
    Brown B
    JAMA; 1997 Jan 22-29; 277(4):295. PubMed ID: 9002483
    [No Abstract]   [Full Text] [Related]  

  • 64. Paralytic poliomyelitis--United States, 1980-1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jan; 46(4):79-83. PubMed ID: 9048844
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Vaccine-derived poliomyelitis 12 years after infection in Minnesota.
    DeVries AS; Harper J; Murray A; Lexau C; Bahta L; Christensen J; Cebelinski E; Fuller S; Kline S; Wallace GS; Shaw JH; Burns CC; Lynfield R
    N Engl J Med; 2011 Jun; 364(24):2316-23. PubMed ID: 21675890
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oral poliovaccine and paralysis.
    Feldman RA; Kamath DK; Christopher S
    Indian Pediatr; 1968 Oct; 5(10):475-8. PubMed ID: 5715225
    [No Abstract]   [Full Text] [Related]  

  • 67. Paralytic poliomyelitis associated with Sabin monovalent and bivalent oral polio vaccines in Hungary.
    Estívariz CF; Molnár Z; Venczel L; Kapusinszky B; Zingeser JA; Lipskaya GY; Kew OM; Berencsi G; Csohán A
    Am J Epidemiol; 2011 Aug; 174(3):316-25. PubMed ID: 21685412
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984.
    Nkowane BM; Wassilak SG; Orenstein WA; Bart KJ; Schonberger LB; Hinman AR; Kew OM
    JAMA; 1987 Mar; 257(10):1335-40. PubMed ID: 3029445
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Poliomyelitis. Evaluation of poliovirus-related cases.
    Wkly Epidemiol Rec; 1990 May; 65(21):159-62. PubMed ID: 2167116
    [No Abstract]   [Full Text] [Related]  

  • 70. Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus.
    Bull World Health Organ; 1969; 40(6):925-45. PubMed ID: 4310724
    [No Abstract]   [Full Text] [Related]  

  • 71. [Vaccination against poliomyelitis].
    Cellesi C; Rossolini A
    Pediatr Med Chir; 1984; 6(1):13-5. PubMed ID: 6099548
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Poliomyelitis in the Federal Republic of Germany. A retrospective study of 1973 (author's transl)].
    Neumann-Haefelin D; Newmann-Haefelin C; Baumeister HG; Knocke KW; Petersen EE; Haas R
    Dtsch Med Wochenschr; 1974 Dec; 99(51):2597-602. PubMed ID: 4373221
    [No Abstract]   [Full Text] [Related]  

  • 73. Vaccine-induced polioencephalomyelitis in Scotland.
    Asindi AA; Bell EJ; Browning MJ; Stephenson JB
    Scott Med J; 1988 Aug; 33(4):306-7. PubMed ID: 2847313
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Vaccine-associated paralytic poliomyelitis in the Russian Federation in 1998-2014.
    Ivanova OE; Eremeeva TP; Morozova NS; Shakaryan AK; Korotkova EA; Kozlovskaya LI; Baykova OY; Krasota AY; Gmyl AP
    Int J Infect Dis; 2018 Nov; 76():64-69. PubMed ID: 30201507
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ala67Thr mutation in the poliovirus receptor CD155 is a potential risk factor for vaccine and wild-type paralytic poliomyelitis.
    Kindberg E; Ax C; Fiore L; Svensson L
    J Med Virol; 2009 May; 81(5):933-6. PubMed ID: 19319949
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Poliomyelitis prevention: revised recommendations for use of inactivated and live oral poliovirus vaccines. American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 1999 Jan; 103(1):171-2. PubMed ID: 9917460
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [The clinico-laboratory characteristics of paralytic poliomyelitis with the regular immunization of children with the Sabin live vaccine].
    Protas II; Fel'dman EV; Rusikevich SS
    Pediatriia; 1992; (10-12):19-22. PubMed ID: 1291953
    [No Abstract]   [Full Text] [Related]  

  • 78. Medical negligence and vaccine associated paralytic poliomyelitis.
    Paul Y
    Indian Pediatr; 2001 Sep; 38(9):1068-9. PubMed ID: 11568394
    [No Abstract]   [Full Text] [Related]  

  • 79. Multiple genetic changes can occur in the oral poliovaccines upon replication in humans.
    Kew OM; Nottay BK; Hatch MH; Nakano JH; Obijeski JF
    J Gen Virol; 1981 Oct; 56(Pt 2):337-47. PubMed ID: 6273502
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Vaccine-associated poliomyelitis in the United States, 1961-1972.
    Schonberger LB; McGowan JE; Gregg MB
    Am J Epidemiol; 1976 Aug; 104(2):202-11. PubMed ID: 181984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.